111
Participants
Start Date
July 16, 2025
Primary Completion Date
May 31, 2026
Study Completion Date
May 31, 2026
Reduction of anticholinergic medication
Shared decision making between the patient and prescriber will determine the timing and speed of reduction over a period of 12 to 16 weeks. Some patients will be discontinued from these anticholinergic medications (benztropine/trihexyphenidyl), others will be tapered from their original dosage but not completely discontinued, and some patients may not be able to taper the anticholinergic medications at all.
NOT_YET_RECRUITING
Comprehensive Recovery Services (Pittsburgh) of Western Psychiatric Hospital, Ambulatory Clinics and Residential Programs - UPMC, Pittsburgh, PA, Pittsburgh
RECRUITING
UPMC Western Behavioral Health at Safe Harbor, Erie
NOT_YET_RECRUITING
Western Behavioral Health of the Alleghenies, Altoona
NOT_YET_RECRUITING
Western Behavioral Health Mon Yough, McKeesport
National Center for Advancing Translational Sciences (NCATS)
NIH
University of Pittsburgh Medical Center
OTHER
University of Pittsburgh
OTHER